COVID-19 CVD Registry: Getting Started, What Your Hospital Needs to Know

Thank you for your interest in the American Heart Association’s COVID-19 CVD Registry. The registry will capture patient clinical characteristics, medications, treatments, labs, vitals, biomarkers and outcomes in adult (≥18 years old) patients hospitalized with COVID-19. A large focus will lie on granular data collection from hospitals that routinely test biomarkers in COVID-19 patients.

While we welcome all hospitals to participate in the quality improvement (QI) program, hospitals with robust systems for running COVID-19 biomarkers on all adult hospitalized COVID-19 patients during the pandemic are highly encouraged to participate. The following information will help hospitals quickly register and access this no-cost opportunity.

Registration

Please email the following information to qualityresearch@heart.org using the subject line, “[your hospital’s name] interest in COVID-19 CVD Registry Participation”

  • Hospital name and location
  • Which Get With The Guidelines® (GWTG) modules hospital currently participates in, if any
  • GWTG Site ID, if participating
  • Name and email of person leading the contracting
  • Name and email of lead physician champion for the registry
  • Do you have an onsite clinical chemistry laboratory? If yes, please describe its capacity for running serial standard blood tests.

Once received, AHA staff will review and contact you with any questions.

Contracting

Once your registration information is received, the American Heart Association will review and contact you with any additional questions and appropriate contractual agreements.

Non-Get With The Guidelines Hospitals:

Hospitals not already contracted for one of our GWTG programs will need to execute an online unified participation agreement (UPA).

Get With The Guidelines Hospitals:

Hospitals already contracted for GWTG through the AHA UPA may:
  1. sign a paper amendment to the UPA; or
  2. complete an online UPA solely for enrollment in COVID-19 CVD Quality Improvement Registry. 
Hospitals who have Participating Hospital Agreements (PHA) with IQVIA may:
  1. execute an online UPA to bring all of their modules under the UPA; or
  2. complete an online UPA solely for enrollment in COVID-19 CVD Quality Improvement Registry.

Note: Similar to the American Heart Association’s existing suite of GWTG programs, the COVID-19 CVD registry is a QI program and data are collected and submitted as part of standard healthcare operations. Most hospitals participating in the other GWTG registries as well as this patient data registry do not require institutional review board (IRB) review. Your hospital IRB will determine whether participation is subject to or exempt from IRB oversight. The U.S. Department of Health & Human Services offers a resource of Quality Improvement Activities FAQs that may help answer your specific IRB questions. 

Data Reporting and Training

When contracting is fully executed, you will receive a paper case report form (CRF) and coding instructions. You may begin collecting data immediately on the paper CRF prior to the online registry going live in early May.

Stay tuned for training opportunities to help your hospital be successful with data collection and the new online tool. AHA will provide a suite of trainings including both videos and office hours that will commence the week of April 20. Additional details forthcoming.

Expect an email from InfosarioOutcomeSupport@quintiles.com with your login information to access the tool in early May. We encourage you to complete your online login soon after receipt to begin entering data as quickly as possible. Should you have technology related questions, please email InfosarioOutcomeSupport@quintiles.com. All program questions should be directed to your local AHA vice president or you may email qualityresearch@heart.org.